#United States #Johnson & Johnson #Palm Beach Gardens #KINCISE #Surgical System

Johnson & Johnson MedTech Unveils KINCISE™ 2 System

On June 3, 2025, Johnson & Johnson MedTech made a significant leap in orthopedic surgery technology with the launch of the KINCISE™ 2 Surgical Automated System. As the only automated surgical impaction tool currently approved for both knee and hip revision procedures, this innovative device aims to improve surgical workflows while alleviating some of the physical stresses faced by orthopedic surgeons.

Addressing Challenges in the Operating Room

The operating room has evolved in complexity, with procedures now requiring longer durations and often higher case volumes. The KINCISE™ 2 System is designed to confront these challenges head-on. Traditional methods, like manual malleting, necessitate high-force repetitions which can contribute to musculoskeletal problems among surgeons. A staggering 97% of surgeons report experiencing pain related to their work. This new system promises to enhance surgical efficiency by minimizing physical strain, enabling surgeons to focus more on patient care and outcomes rather than the physical demands of their work.

Dr. Vasilios Mathews, a prominent orthopedic surgeon at Texas Orthopedic Hospital, emphasizes the impact of this technology, stating, "The KINCISE™ 2 System helps surgeons stay at their best, longer." By reducing the physical burden and enhancing precision in surgical procedures, surgeons can devote more attention to their patients, fundamentally transforming the surgical experience.

Enhanced Features for Improved Performance

The KINCISE™ 2 builds upon its predecessor, the original KINCISE™ System, incorporating several advancements that fortify its functionality. Notably, the addition of reverse energy features and push-to-lock adaptors streamlines the surgical workflow, facilitating a smoother operation. The KINCISE™ 2 System also introduces the Acetabular Cup Extraction function, making it the first automated impactor capable of removing well-fixed acetabular components. This versatility significantly enhances its applicability, especially in complex hip revision surgeries, and aligns well with advanced surgical techniques such as the Anterior Approach.

A Commitment to Better Outcomes

Aldo Denti, Company Group Chairman for Orthopaedics at Johnson & Johnson MedTech, highlights the rising demand for revision surgeries as more patients receive joint replacements at an earlier stage in life. He states, "The KINCISE™ System helps surgeons manage complex cases effectively by reducing operating time and ensuring procedural control, which collectively supports better outcomes for patients." The system's availability in the United States underscores Johnson & Johnson MedTech's dedication to innovating and adapting technologies that address significant challenges faced by modern orthopedic surgeons.

A Pioneering Approach to MedTech Solutions

Johnson & Johnson's overarching mission is to tackle some of the most intricate health challenges globally. The launch of the KINCISE™ 2 System is a testament to their innovative approach, leveraging extensive expertise in joint reconstruction and surgical technology. This system not only aims to improve the surgical experience for surgeons but also fosters a more standardized and overwhelming surgical experience for patients across the board.

For more detailed information about KINCISE™ 2, visit Johnson & Johnson MedTech's official website.

In conclusion, as the medical field continues to push the boundaries of excellence, the KINCISE™ 2 Surgical Automated System stands out as a pioneering product that enhances surgical precision and efficiency, while alleviating the physical toll on surgeons, ultimately aiming to improve patient care significantly.